BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19767013)

  • 1. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.
    Coccaro EF; Lee R; Kavoussi RJ
    J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
    Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
    Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects.
    Marseille R; Lee R; Coccaro EF
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):277-81. PubMed ID: 22019855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects.
    Goveas JS; Csernansky JG; Coccaro EF
    Psychiatry Res; 2004 Apr; 126(1):23-32. PubMed ID: 15081624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.
    Coccaro EF; Lee R; Kavoussi RJ
    Neuropsychopharmacology; 2010 Jan; 35(2):435-44. PubMed ID: 19776731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding.
    Coccaro EF; Kavoussi RJ; Sheline YI; Berman ME; Csernansky JG
    Neuropsychopharmacology; 1997 Mar; 16(3):211-6. PubMed ID: 9138437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of personality disorder with intermittent explosive disorder.
    Coccaro EF; Shima CK; Lee RJ
    J Psychiatr Res; 2018 Nov; 106():15-21. PubMed ID: 30240963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients.
    Gelegen V; Tamam L
    Compr Psychiatry; 2018 May; 83():64-70. PubMed ID: 29604524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.
    Patkar AA; Gottheil E; Berrettini WH; Hill KP; Thornton CC; Weinstein SP
    Am J Addict; 2003; 12(5):432-47. PubMed ID: 14660157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
    Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verbal versus physical aggression in Intermittent Explosive Disorder.
    Look AE; McCloskey MS; Coccaro EF
    Psychiatry Res; 2015 Feb; 225(3):531-9. PubMed ID: 25534757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.
    Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B
    Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
    van de Giessen E; Rosell DR; Thompson JL; Xu X; Girgis RR; Ehrlich Y; Slifstein M; Abi-Dargham A; Siever LJ
    J Psychiatr Res; 2014 Nov; 58():147-54. PubMed ID: 25145808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria.
    Coccaro EF; Kavoussi RJ; Berman ME; Lish JD
    Compr Psychiatry; 1998; 39(6):368-76. PubMed ID: 9829145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia.
    Maguire K; Cheung P; Crowley K; Norman T; Schweitzer I; Burrows G
    Schizophr Res; 1997 Jan; 23(1):61-7. PubMed ID: 9050129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased density of the platelet serotonin transporter in pathological gamblers.
    Marazziti D; Golia F; Picchetti M; Pioli E; Mannari P; Lenzi F; Conversano C; Carmassi C; Catena Dell'Osso M; Consoli G; Baroni S; Giannaccini G; Zanda G; Dell'Osso L
    Neuropsychobiology; 2008; 57(1-2):38-43. PubMed ID: 18451636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity.
    Coccaro EF; Fridberg DJ; Fanning JR; Grant JE; King AC; Lee R
    J Psychiatr Res; 2016 Oct; 81():127-32. PubMed ID: 27442963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a screening questionnaire for DSM-5 intermittent explosive disorder (IED-SQ).
    Coccaro EF; Berman ME; McCloskey MS
    Compr Psychiatry; 2017 Apr; 74():21-26. PubMed ID: 28088746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.
    Coccaro EF; Lee RJ; Kavoussi RJ
    J Clin Psychiatry; 2009 Apr; 70(5):653-62. PubMed ID: 19389333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.